ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups

April 18, 1975

FASEB: Focus on Research Funding, Not PR

June 14, 2013

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis

March 17, 1989

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

Brinker Again To Lead Komen As CEO

December 11, 2009